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Human complement factor H: two factor H 
proteins are derived from alternatively spliced 
transcripts* 
The human complement factor H is an important component in the control of the 
alternative pathway of complement activation. We have previously shown that at 
least three factor H homologous mRNA species of 4.3 kb, 1.8 kb and 1.4 kb in 
length are constitutively expressed in human liver. In addition, several factor H- 
related proteins have been detected in human sera using antibodies directed 
against the classical human factor H glycoprotein of 150 kDa.The structure of the 
additional polypeptides has not been shown so far. Circumstantial evidence 
suggests that the 1.8-kb mRNA might encode the 43-kDa factor H-like 
polypeptide. Here we report the isolation, characterization and eukaryotic 
expression of the first full-length cDNA representing the major 4.3-kb mRNA 
and the 1.8-kb mRNA of human factor H. We show that the 4.3-kb transcript 
encodes the 150-kDa-factor H glycoprotein and the 1.8-kb mRNA the 43-kDa 
factorH polypeptide. The identity of the two cDNA in a region of 1400 
nucleotides suggests that the two factor H-related transcripts are derived from 
one gene by a process of alternative splicing. 
1 Introduction 
Factor H, a regulatory protein of the complement system, 
controls the alternative pathway of complement activation 
by competing for the interaction of C3b with factor B and 
C5 and by dislodging the Bb fragment of factor B from the 
active alternative pathway convertase (C3bBb), thus accel- 
erating the decay of this enzyme [l-31. 
Factor H also functions as a cofactor for factor I cleavage of 
C3b to inactivated C3b (iC3b) [4]. All these functions have 
been located on a 38-kDa aminoterminal fragment 
obtained by limited tryptic digestion of the major 150-kDa 
factor H protein derived from serum [5]. No biological 
activities have yet been assigned to the remaining 120-kDa 
portion of factor H [6, 71. 
For human factor H, three different mRNA species of 
4.3 kb, 1.8 kb and 1.4 kb are constitutively expressed in 
liver [8]. Recently shorter factor H-related polypeptides 
have been detected in human serum using polyclonal or 
monoclonal anti-factor H reagents. It is not clear whether 
these proteins are derived from the 150-kDa factorH 
glycoprotein by post-translational processing or whether 
they are encoded by the smaller factor H-related mRNA 
species present in liver [8, 91. cDNA clones have been 
isolated and sequenced which represent the 1.8-kb mRNA 
species [lo-131. To date none of these cDNA encode 
functional 1.8-kb transcripts containing the correct 5' 
sequence. For this reason it was not possible to demonstrate 
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which, if any, of the short factor H-like proteins detected in 
serum are derived from the 1.8-kb transcript. We have 
previously identified and purified a novel factor H protein 
of 43 kDa from human plasma which is the most likely 
translational product for the 1.8-kb factor H mRNA in vivo 
[8, 141. 
The amino acid sequence of the classical factor H 
(150 kDa) has been compiled from protein sequence data 
and overlapping cDNA sequences [13, 151. Thus, it has 
been found that the translation products of the 4.3-kb and 
1.8-kb factor H mRNA species share the amino terminal 
sequence, and it has been proposed that both transcripts are 
obtained from one factor H gene by a process of alternative 
splicing [ll, 131. Clear evidence is lacking, as no cDNA 
with the 5' sequence unambiguously derived from the 
4.3-kb mRNA has been isolated so far. 
In order to study the complexity of factor H-like proteins 
and transcripts, we constructed a liver cDNA library in the 
eukaryotic expression vector CDM8 [16]. Full-length 
cDNA clones were isolated (pFH4.3 and pFH1.8) both for 
the 4.3-kb and the 1.8-kb mRNA species, respectively. By 
transient expression in COS cells, it can be shown that 
pFH4.3 codes for the 150-kDa factor H serum protein and 
pFH1.8 for the 43-kDa factor H-like polypeptide. DNA 
sequence data obtained from the 5' and 3' termini of the 
cDNA clones demonstrate that both transcripts are derived 
from one factor H gene. 
2 Materials and methods 
2.1 Construction and screening of a human cDNA 
library in the eukaryotic expression vector CDMS 
RNA was prepared from human liver tissue by extraction 
with guanidinium thiocyanate and centrifugation through a 
cesium chloride gradient (171. Poly(A)+RNA was purified 
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by oligo(dT) cellulose chromatography. Approximately 
15 pg poly(A)+RNA was employed for cDNA synthesis 
using the kit supplied by BRL, Karlsruhe, FRG. Size- 
selected cDNA fragments (> 1 kb) were ligated with 
Bst XI linker and cloned into purified Bst XI-linearized 
vector CDM8, following exactly the protocol provided by 
Dr. B. Seed, Boston, MA [16, 181. About 300000 colonies 
were differentially screened with the following probes: H19 
cDNA insert, hybridizing to the 4.3-kb and 1.8-kb mRNA, 
the 3’ Bgl I/Pst I fragment of H19 detecting only the 1.8-kb 
transcript and H46 cDNA insert hybridizing to the 4.3-kb 
and 1.4-kb transcripts [8, 111. More than 100 positive 
colonies were obtained with each probe. Only clones which 
might represent the full-length cDNA transcripts of the 
4.3-kb and 1.8-kb mRNA were further characterized by 
restriction enzyme and DNA sequence analysis. 
2.2 Restriction enzyme and DNA sequence analysis 
The complete cDNA inserts could be excised with the 
restriction enzymes Sac I and Pst I present in the linker 
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Figure I .  Full-length factor H cDNA clones in the vector CDM8. 
The restriction maps of the full-length cDNA clones pFH4.3 
(factor HgplsO) and pFH1.8 (factor H*3) is shown for the following 
restriction enzymes: B, Bgl 11. E, Eco RV; H, Hind 111; P, Pst I; S, 
SmaI. Short horizontal arrows show the direction of DNA 
sequence determination with oligonucleotides localized in the 
CDM8 linker region. 
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region of CDM8. DNA sequence analysis was performed 
with T7 polymerase and the reagent kit supplied by 
Pharmacia, Freiburg, FRG. Plasmid DNA was directly 
sequenced with two oligonucleotides, ocdm8-1 
(CTGGCTAACTAGAGAAC) located 5‘ and ocdm8-2 
(GATCCTCTAGAGTCGC) located 3’ of the Bst XI clon- 
ing site. 
2.3 Northern blot analysis and hybridization 
Approximately 1 pg of liver poly(A)+RNA was separated 
on a formaldehyde agarose gel, blotted to nylon membrane 
(Hybond N,  AmershadBuchler, Braunschweig, FRG) 
following standard protocols [19] and hybridized with the 
4.3-kb SacIRstI fragment of pFH4.3, the 1.8-kb 
HindIII/PstI insert of pFH1.8, and the 250-bp 
Eco RV/Pst I fragment of pFH4.3.The probes were labeled 
with a[32P]dATP according to the random priming proce- 
dure [20]. Hybridization at a concentration of 5 x 106 cpm 
labeled fragmendml hybridization solution and washing of 
colony filters and Northern blots was carried out by the 
method of Church and Gilbert [21]. 
2.4 COS cell transfection 
The cDNA clones pFH4.3 and pFH1.8, and the vector 
CDM8 as control DNA were transfected into COS cells by 
electroporation using the Gene PulserTM apparatus (Bio- 
Rad, Munich, FRG) following the recommendations of the 
supplier. Briefly, 0.8 ml of COS cell suspension (1 x lo7 
cells/ml) were mixed with 60 pg DNA. Electroporation was 
performed in 272 mM sucrose, 7 mM Na2HP04, pH 7.4, 
and 1 mM MgC12 with 380 V and 250 pF in the cold. The 
cells were then diluted with DMEM/25 mM Hepes medium 
containing 10% FCS and cultured in 9-cm petri dishes. 
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Figure 2. Partial nucleotide and derived 
amino acid sequences of factor H. (a) The 
5’ sequence of the cDNA clones pFH4.3 
and pFH1.8 is compared as far as deter- 
mined. (b) The 3’ sequence of pFH1.8 is 
shown in comparison with the cDNA 
clone B38-1 also derived from the 1.8-kb 
mRNA. Here the nucleotide numbering 
corresponds to the B38-13’ sequence [ 131. 
Sequence identity of the pFH4.3 sequence 
ending exactly with SCR 7 is indicated by 
dots. (c) The 3’ sequence of pFH4.3 is 
shown in comparison with the fac- 
tor HgpIso-derived sequence R2a [7, 13). 
The Hind 111 recognition sequence is pres- 
ent at position 3635. Here the nucleotide 
numbering corresponds to the R2a 
sequence. The putative polyadenylation 
signal in pFH4.3 is underlined. 
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After 24-h the medium was changed to DMEM containing 
1 X Nutridoma HU (Boehringer Mannheim, Mannheim, 
FRG). SN were collected 72 h after the pulse, concentrated 
20-fold, and assayed for the expression of factor H or 
factor H-related proteins by Western blot analysis. 
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2.5 Western blot analysis 
SN of COS cell transfectants (80 pl) and human serum 
(3 p1) were analyzed by SDS-PAGE on a 10% gel under 
nonreducing conditions [22] and blotted to nitrocellulose 
according to the method of Towbin et al. [23]. Blots were 
stained with the mAb MAH-4 [ll] and peroxidase-conju- 
gated anti-mouse IgG using standard protocols. 
3 Results 
3.1 Isolation of the full-length cDNA clones pFH4.3 
and pFH1.8 
The orientation of the cDNA clones was determined by 
digestion with HindIII which cuts in the 3' region of the 
4.3-kb cDNA [13] and in the 5' linker sequence of the 
vector CDM8 (see Figs. 1 and 2). The extent of the cloned 
5' sequence was resolved by digestion with HindIII and 
Bgl I1 . 
Only one cDNA clone (pFH4.3) was found which con- 
tained a 4.3-kb insert in the correct 5' to 3' orientation. 
Determination of the DNA sequence of the 5' and 3' ends 
of the insert confirmed the orientation and that this cDNA 
was full length (see Fig. 2). All other clones hybridizing to 
both the H19 and H46 insert represented truncated cDNA 
of the 4.3-kb mRNA. 
pFH4.3 is, in the region sequenced (222 bp of the 5' 
sequence and 751 bp of the 3' sequence), identical to the 
previously published factor H cDNA clones B38-1 and 
R2a. Thus, it contains 54 nucleotides of 5' untranslated 
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Figure 3. Northern blots of poly(A)+RNA from human liver. 
About 1 pg of poly(A)+ liver RNA was separated on an aga- 
rose/formaldehyde gel, transferred to nylon membrane and hybrid- 
ized with the full-length pFH4.3 cDNA insert (a), the 250-bp 
Eco RVPst I fragment of pFH4.3, coding for the 3' end of the 
4.3-kb mRNA ((b) lane 11 and the full-length pFH1.8 cDNA insert 
[(b), lane 21; Fig. 3a is derived from a different gel than 
Fig. 3b. 
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Figure 4. Western blot analysis for factor H expression in COS cell 
transfectants. Normal human serum, concentrated SN and cell 
lysates of the transfection assays were subjected to SDS-PAGE 
under nonreducing conditions and then analyzed by Western 
blotting with the anti-factor H mAb MAH-4. (a), Lane 1: 3 p1 of 
human serum, lane 2: 80 kl of 20-fold concentrated SN of CDM8 
COS cell transfectants, lane 3: lysate of 1 X 106 pFH4.3 transfected 
COS cells, lane 4: lysate of 1 x 1 8  CDM8 transfected COS cells, 
lane 5: 80 pl of 20-fold concentrated SN of COS cells transfected 
with pFH4.3 at 250 p5 and 350 V, lane 6: same as 5 but electropo- 
ration was performed with a 380-V pulse. (b), Lane 1: 3 pl of 
human serum, lane 2: 80 pl of 20-fold concentrated SN of CDM8 
COS cell transfectants, lane 3: 80 pl of 20-fold concentrated SN of 
COS cells transfected with pFH1.8 at 250 pF and 250 V, lane 4: 
same as 3 but electroporation was performed with a 380-V pulse. 
On the left, sizes of the detected factor H proteins are indicated in 
kDa. 
sequence and 189 nucleotides of 3' untranslated region 
which is 29 nucleotides longer than the R2a cDNA 
sequence ([ 131, see Fig. 2). Tbo putative polyadenylation 
signals are present in pFH4.3 at positions 3810 and 3942. 
Previous factor H cDNA clones ended prior to the second 
polyadenylation signal. The length of the 3' untranslated 
region of pFH4.3 and of shorter factor H cDNA clones 
indicate that the second ATTAAA signal is recognized in 
human liver. This is confirmed by the same 3' terminal 
sequence in H46 cDNA (Barbieri, Dierich, Schwaeble, 
unpublished results), isolated from a liver cDNA library 
prepared from RNA of another donor. 
Several cDNA clones of 1.8 kb in length were characterized 
which hybridized to both the 5' and 3' fragment of H19, and 
thus should be derived from the 1.8-kb factor H mRNA. 
Only one full-length clone, pFH1.8, had the right orienta- 
tion and could therefore directly be used for transfection. 
The completeness of this cDNA was confirmed by sequenc- 
ing both ends (see Figs. 1 and 2). It contains 48 nucleotides 
of 5' untranslated region and the 5' nucleotide sequence is 
identical to pFH4.3. pFH1.8 corresponds to the previously 
published B38-1 cDNA, but does not contain any cloning 
artifact such as inversion within the 5' sequence present in 
the previously described cDNA clones B38-1 [13] and H20 
[8].Thus, it has the same unique 3' end as reported for the 
truncated cDNA B38-1, pH1050 [12] and H19 [ll], char- 
acteristic for cDNA derived from the 1.8-kb factorH 
transcript (see Fig. 2). 
Previous Northern blot results with different cDNA probes 
showed three factor H-related transcripts in human liver 
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[8]. We used the full length 4.3-kb cDNA insert to probe 
poly(A)+RNA from human liver and detected the same 
three mRNA species as obtained with subfragments (see 
Fig. 3), suggesting that the smallest 1.4-kb factor H-related 
mRNA also represents a truncated form of the large 4.3-kb 
transcript. 
3.2 Eukaryotic expression of factor H proteins encoded 
by pFH4.3 and pFH1.8 
As the liver cDNA library was constructed in the eukaryotic 
expression vector CDM8, the cDNA clones could be tested 
directly for the encoded proteins by transient expression in 
COS cells [16]. FactorH is a secreted protein, for this 
reason we tested SN as well as cell lysates of individual 
transfection assays. As shown in Fig. 4a, pFH4.3 codes for 
a 150-kDa factor H protein which, in this assay, is indistin- 
guishable from the major abundant factor H protein in 
human serum. No shorter factor H protein was detected in 
SN or cell lysates fo pFH4.3 transfectants. Therefore, it is 
unlikely that the smaller factor H-related proteins detected 
with anti-factor H reagents are derived from the 150-kDa 
protein by posttranslational processing events. Further- 
more, the eukaryotic expression of pFH1.8, which repre- 
sents the complete 1.8-kb factor H transcript, encodes a 
43-kDa factor H protein demonstrating that this mRNA 
encodes a truncated factor H protein identical to that found 
in serum (see Fig. 4b). 
4 Discussion 
The results reported here demonstrate that the cDNA 
clones pFH4.3 and pFHl.8 represent full-length cDNA 
sequences derived from transcripts of the 4.3-kb and the 
1.8-kb mRNA species of human factor H. The eukaryotic 
expression of both cDNA has proven that the 4.3-kb 
mRNA encodes the large classical 150-kDa factor H pro- 
tein, while an additional truncated factor H-like protein of 
43 kDa is encoded by the 1.8-kb mRNA. As both factor H 
proteins contain the apparent functional domains of cofac- 
tor H known so far, we propose the nomenclature fac- 
tor HgplsO and factor Hp43 to distinguish between the two 
molecules. Although the protein sequence of pFH1.8 
contains one potential glycosylation site for Asn-linked 
carbohydrate, no evidence for such a modification of the 
43-kDa factor H polypeptide in human serum has been 
found [13]. Several reports have to date described a 
truncated form of factor H and on SDS gels have shown a 
molecular weight of 41 000-45000, much shorter than the 
calculated M, of 49000 [8,9,  13l.This discrepancy in M, is 
difficult to explain as a mobility artifact on SDS-PAGE, but 
may indicate post-transcriptional modification such that 
some amino acid residues, presumably of the carboxy 
terminus, have been removed. Our cDNA clones should be 
useful in future to produce recombinant native and mutant 
factor H proteins for the study of the complex functions of 
these factors. 
The sequence identity of pFH4.3 and pFH1.8 in the 5' part 
combined with the published sequences for the 4.3-kb and 
the 1.8-kb factor H cDNA clones covering in total 1400 
nucleotides can only be explained by one gene coding for 
both transcripts. The arrangement of exactly the same 5' 
untranslated region, in addition to an identical open 
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reading frame in both mRNA (see this report, 111-13]), 
strongly suggests that they arise by alternative splicing from 
the transcription product of a single structural gene. This 
conclusion is supported by the partial gene structure for 
human factor H recently described by McAleer et al. [24], 
containing an extra exon encoding the specific 3' end of the 
1.8-kb transcript. In data reported here, the smallest 
transcript of 1.4-kb hybridized with only the 3' factor Hgpl?" 
cDNA probes but not with 5' fragments. The origin of this 
mRNA is unknown so far. Cloning of the 1.4-kb transcript 
coding for factor H-related molecules will show whether 
this mRNA is also derived from the common factor H gene 
and whether it only codes for a carboxyterminal fragment 
of factor HgPlso. 
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